Sei Investments Co. lifted its stake in shares of Teleflex Incorporated (NYSE:TFX – Free Report) by 23.8% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 102,611 shares of the medical technology company’s stock after buying an additional 19,707 shares during the quarter. Sei Investments Co.’s holdings in Teleflex were worth $18,263,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also modified their holdings of the company. HighTower Advisors LLC lifted its position in Teleflex by 1.7% during the third quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company’s stock worth $986,000 after acquiring an additional 66 shares during the last quarter. Hengehold Capital Management LLC lifted its holdings in Teleflex by 7.3% during the 4th quarter. Hengehold Capital Management LLC now owns 1,289 shares of the medical technology company’s stock worth $229,000 after purchasing an additional 88 shares during the last quarter. Exchange Traded Concepts LLC boosted its stake in Teleflex by 38.2% in the 4th quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company’s stock valued at $61,000 after purchasing an additional 94 shares during the period. Isthmus Partners LLC grew its holdings in Teleflex by 7.3% in the 4th quarter. Isthmus Partners LLC now owns 1,535 shares of the medical technology company’s stock valued at $273,000 after buying an additional 105 shares in the last quarter. Finally, Sumitomo Mitsui DS Asset Management Company Ltd grew its holdings in Teleflex by 2.4% in the 4th quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 4,991 shares of the medical technology company’s stock valued at $888,000 after buying an additional 118 shares in the last quarter. Institutional investors own 95.62% of the company’s stock.
Analyst Ratings Changes
TFX has been the subject of a number of research reports. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research report on Wednesday, March 12th. Citizens Jmp downgraded shares of Teleflex from an “outperform” rating to a “market perform” rating in a report on Thursday, February 27th. Wells Fargo & Company lowered their target price on shares of Teleflex from $214.00 to $146.00 and set an “equal weight” rating on the stock in a report on Friday, February 28th. StockNews.com cut Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, February 28th. Finally, Piper Sandler restated a “neutral” rating and set a $140.00 price objective (down previously from $255.00) on shares of Teleflex in a research note on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $182.63.
Teleflex Price Performance
Teleflex stock opened at $139.34 on Friday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. Teleflex Incorporated has a 52 week low of $128.55 and a 52 week high of $249.91. The stock has a market capitalization of $6.46 billion, a P/E ratio of 27.70, a price-to-earnings-growth ratio of 1.73 and a beta of 1.21. The stock has a fifty day moving average of $160.07 and a 200-day moving average of $191.50.
Teleflex (NYSE:TFX – Get Free Report) last released its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.86 by $0.03. The firm had revenue of $795.40 million for the quarter, compared to analysts’ expectations of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. On average, sell-side analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.
Teleflex Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were paid a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 0.98%. The ex-dividend date of this dividend was Friday, March 7th. Teleflex’s payout ratio is 95.77%.
Teleflex Company Profile
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Recommended Stories
- Five stocks we like better than Teleflex
- What is diluted earnings per share (Diluted EPS)?
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- The Risks of Owning Bonds
- Top 3 Beverage Stocks Pouring Out Profits
- What is a Bond Market Holiday? How to Invest and Trade
- CarMax and Carvana: Steering the Used Car Market
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX – Free Report).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.